Frontobasal gray matter loss is associated with the TREM2 p.R47H variant

Elkin O Luis1, Sara Ortega-Cubero2, Isabel Lamet3

  • 1Neuroimaging Laboratory, Division of Neurosciences, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain.

Neurobiology of Aging
|July 17, 2014
PubMed

Insights

The TREM2 p.R47H variant, linked to Alzheimer's disease (AD) risk, is associated with specific clinical and brain imaging features. This variant shows preferential gray matter loss in frontobasal and temporal regions.

Area of Science:

  • Neuroscience
  • Genetics
  • Radiology

Background:

  • The TREM2 p.R47H variant (rs75932628) is a known risk factor for Alzheimer's disease (AD).
  • Understanding the specific clinical and neuroimaging correlates of this variant is crucial for AD research.

Purpose of the Study:

  • To investigate the clinical presentation, neuropsychological profile, and regional gray and white matter loss in individuals with the TREM2 p.R47H variant.
  • To identify brain regions that best differentiate TREM2 p.R47H carriers from non-carriers.

Main Methods:

  • Cross-sectional study involving 16 TREM2 p.R47H carriers with AD or mild cognitive impairment, 75 AD non-carriers, and 75 cognitively intact non-carriers.
  • Clinical assessment, neuropsychological testing, and voxel-based morphometry using brain MRI (Statistical Parametric Mapping).
  • Analysis performed on two independent sample sets (Spanish and ADNI1) with joint and conjunction analyses.

Main Results:

  • Spanish carriers exhibited higher rates of apraxia and psychiatric symptoms compared to non-carriers.
  • Voxel-based morphometry revealed significant gray matter loss in the orbitofrontal cortex and anterior cingulate cortex in carriers.
  • Relative preservation of parietal lobes was observed in carriers, alongside previously noted temporal lobe atrophy.

Conclusions:

  • The TREM2 p.R47H variant is associated with distinct clinical features, including behavioral symptoms and apraxia.
  • Preferential gray matter loss in frontobasal and temporal regions suggests these areas are particularly vulnerable to the variant's effects.
  • These findings contribute to understanding the specific pathological mechanisms underlying AD in TREM2 p.R47H carriers.

Related Concept Videos

Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
27
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
19
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
20